About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Clinical and Molecular Hepatology
›
Top Articles
Clinical and Molecular Hepatology
Hepatology
,
Biology
,
Molecular Biology
6.9
(top 2%)
Impact Factor
7.5
(top 2%)
extended IF
44
(top 9%)
H-Index
215
authors
515
papers
8.7K
citations
1.6K
citing journals
6.7K
citing authors
Most Cited Articles of Clinical and Molecular Hepatology
Title
Year
Citations
Cost-of-illness studies: concepts, scopes, and methods
2014
277
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
2013
241
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
2016
199
KASL clinical practice guidelines: management of chronic hepatitis B
2016
141
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
2012
129
Genetic predisposition in nonalcoholic fatty liver disease
2017
112
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
2019
104
Epidemiology of liver cancer in South Korea
2018
100
Hepatitis C virus: virology and life cycle
2013
98
Hepatitis C virus-induced hepatocellular carcinoma
2015
93
Drug-induced liver injury: present and future
2012
92
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease
2013
88
KASL clinical practice guidelines for management of chronic hepatitis B
2019
87
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
2012
84
Hepatic venous pressure gradient: clinical use in chronic liver disease
2014
78
Clinical applications of transient elastography
2012
74
Important predictor of mortality in patients with end-stage liver disease
2013
73
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
73
The mutational landscape of hepatocellular carcinoma
2015
72
Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
2012
68
Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period
2012
66
Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
2014
65
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system
2017
64
Hepatitis C virus and hepatocarcinogenesis
2012
64
Current status and strategies for hepatitis B control in Korea
2017
63
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.